RAN and amyotrophic lateral sclerosis: Since RanGTPase is implicated in ALS pathophysiology and in the PBMC signature presented in Figs. 3 and 5 we chose to assess a readily measurable potential feedback response: degradation of total RanGTPase, even though only a small subfraction of RanGTPase is hypothesized to be involved in ALS pathophysiology.